SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-19-013132
Filing Date
2019-03-06
Accepted
2019-03-06 16:06:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a19-6000_1424b5.htm 424B5 336130
2 GRAPHIC g60001bg13i001.jpg GRAPHIC 2754
3 GRAPHIC g60001bg01i001.jpg GRAPHIC 2146
4 GRAPHIC g60001bg07i001.jpg GRAPHIC 2092
  Complete submission text file 0001104659-19-013132.txt   347307
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-219851 | Film No.: 19662570
SIC: 2836 Biological Products, (No Diagnostic Substances)